1. PD-0416: Daily adaptive strategy simulation in lung cancer pts treated with RTCHT with reduced CTV-PTV MARGIN. (November 2020) Authors: Bonu, M.L.; Borgetti, P.; Spiazzi, L.; Taddeo, A.; Volpi, G.; Guaineri, A.; Costantino, G.; Donofrio, A.; Guerini, A.; Tomasini, D.; Toraci, C.; Imbrescia, J.; Magrini, S.M. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S225 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PO-0843: Assessment of weight loss and subjective dysphagia after radiotherapy for head and neck cancer. (November 2020) Authors: Maddalo, M.; Costantino, G.; Buglione, M.; Spiazzi, L.; Volpi, G.; Premi, A.; Donofrio, A.; Guerini, A.; Alghisi, A.; Pedretti, S.; Costa, L.; Greco, D.; Cominardi, C.; Pegurri, L.; Magrini, S.M. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S454 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PO-0885 Comprehensive geriatric assessment tools for elderly patients with early NSCLC treated with SBRT. (April 2019) Authors: Cuccia, F.; Donofrio, A.; Valenti, V.; Tripoli, A.; Luca, N.; Palmeri, A.; Terranova, G.; Quartuccio, E.; Napoli, G.; De Gregorio, G.; Cespuglio, D.; Mortellaro, G.; Ferrera, G.; Casto, A. Lo Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S467 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PO-1028: Consolidation therapy with Durvalumab after radical CRT in stage IIII NSCLC: a preliminar analysis. (November 2020) Authors: Borghetti, P.; Volpi, G.; Imbrescia, J.; Bonù, M.L.; Guerini, A.; Turla, O.; Maddalo, M.; Vitali, P.; Triggiani, L.; Donofrio, A.; Buglione, M.; Magrini, S.M. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S547 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PO-1494 Universal testing for SARS-Cov-2 in patients undergoing anticancer treatment. (August 2021) Authors: Guerini, A.E.; Magrini, S.M.; Borghetti, P.; Volpi, G.; Luca, T.; Costa, L.; Pegurri, L.; Guaineri, A.; Imbrescia, J.; Ranghetti, E.; Premi, A.; Donofrio, A.; Spiazzi, L.; Buglione, M. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S1225 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗